HIV diagnostics Market Size, Segmentation To 2022: Grand View Research, Inc.

HIV, also known as human immune deficiency virus, spreads through sexual contact with an HIV-infected person. It is the virus that causes AIDS, a condition wherein the body losses its immunity towards infectious diseases and succumbs to them. The HIV diagnostics market deals with all such medical instruments and tests that are utilized to detect whether a person has contracted HIV/AIDS. HIV is found in blood and other body fluids. The worldwide market is estimated to expand to about USD 4.5 billion by the end of 2022.

Access this full report at : http://www.grandviewresearch.com/industry-analysis/hiv-diagnostics-market

Outlook

The vital component which is responsible for the expansion of the HIV diagnostics market includes rising requirement for the development of more sensitive point of care tests for HIV detection. These tests can be simply adopted at the site of patient care in resource restricted settings. Technological upgradation of tests which is estimated to bring forth various point of care and novel rapid tests during the forecast phase is another prime factor, positively impacting the HIV diagnostics market.

Moreover, governmental programs and crusades against HIV and worldwide medical attempts towards reducing illnesses are likely to serve as future prospects for the market. Huge unmet needs in the Eastern and Middle Eastern regions of the world also act as future growth opportunities for the HIV diagnostics market. The worldwide market was anticipated at around USD 2, 173 million in 2014. It is likely to expand at about 9.5 percent CAGR through the forecast phase.

Read detailed report or request for Sample copy this research report:
http://www.ni2014.org/research/hiv-diagnostics-market-outlook-trends-and-forecasts-2015-to-2022#ert_pane1-1

Rising HIV population, developments in medical technologies and growing awareness regarding HIV/AIDS are the other critical factors that push further development of the HIV diagnostics market. Shortage of medical labs with advanced facilities and scarcity of skilled medical experts capable of performing routine tests are the two main factors which prevent the market from developing further. Augmented need for easily available, fast HIV and effective diagnostics tests is also expected to propel the sales of the HIV diagnostics market.

The anticipated boost in product offerings to the worldwide market is also poised to support the sales of the market. Laboratory restrictions come in the way of the HIV diagnostics market. Intensifying promiscuous behavior involving multiple partners and growing ‘high risk category’ population also amplify the utilization of HIV diagnostics. This factor also drives further demand for the market.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics

Significant Findings

HIV diagnostic tests involving the detection of antibodies to HIV occupied the biggest share in 2014. This big share can be credited to the high infiltration rates of HIV tests, such as Elisa, Rapid, Western Blot in theHIV diagnostics market. These tests are very accurate and sensitive and are utilized for the testing and confirmation of HIV. CD4 and Viral Load Testing also captured significant shares in 2014.

Rising HIV diagnostic products are estimated to further the sales of the HIV diagnostics market.North America held the biggest share in 2014. It leaded the worldwide market. This was in view of supportive repayment policies for HIV and other communicable diseases. The Asian Pacific HIV diagnostics market is projected to augment more rapidlythan the North American region through the forecast phase.

For More Information about site: http://www.ni2014.org/

Diabetic Retinopathy Market Size, Segmentation To 2022: Grand View Research, Inc.

Diabetic retinopathy refers to an eye disorder that injures the retina’s blood vessels. The light-sensitive interior eye surface on which images are produced is known as the retina. Diabetes can impact the retina in the long run. This is owing to high levels of blood glucose injuring the retina’s small blood vessels. The management of diabetic retinopathy relies on the phase of the illness. It is led forward to hinder or prevent the disease from advancing further. Anti-VEGF drugs, laser surgery and vitrectomy are some of the treatments available.

Access this full report at : http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market

Outlook

Rising diabetes cases around the world are expected to steer further demand for the diabetic retinopathy market. The worldwide market was predicted to have collected an income worth around 5, 934 million in 2014. It is projected to rise at about 6.8 percent CAGR through the forecast phase. Growing blindness cases triggered by diabetes also further the market.

Read detailed report or request for Sample copy this research report:
http://www.ni2014.org/research/diabetic-retinopathy-market-outlook-trends-andpredictions-2015-to-2022#ert_pane1-1

The diabetic retinopathy market includes screening of the retina and choice of treatment based on how severe the condition is.Moreover, augmenting population of the elderly is also estimated to improve the applicability of the market, thus propelling the same. Financialsustainability on account of 11 percent worldwide medical expenses in the management and prevention of this illness is a primary driver for emergent regions to endorse the diabetic retinopathy market.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Categories

The various categories into which the diabetic retinopathy market is divided are treatments, kinds and geographies. The treatments market consists of intraocular steroid injections, anti-VEGF treatment, vitrectomy and laser surgery.

The market, on account of kinds, is segmented into non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. The geographies diabetic retinopathy market is fragmented on the basis of Europe, rest of the world, North America and Asia Pacific.

Leaders

The treatments diabetic retinopathy market is likely to be dominated by the anti-VEGF sector. This sector is predicted to occupy the biggest share through the forecast phase. This is due to connected attributes, such as quicker recuperation and improved treatment. The kinds diabetic retinopathy market was dominated by the sector of non-proliferative diabetic retinopathy in 2014. This sector made up for the biggest share. This was on account of several patients within an illness history of less than ten years.

Growing diabetes cases, non-compliant screening of retina and falling short of exact detection are the drivers of the non-proliferative diabetic retinopathymarket sector. Proliferative diabetic retinopathy is estimated to experience profitable expansion in the future.This expansion is expected owing to the rising population of old people entering the proliferative phase of retinopathy. The geographies diabetic retinopathy market was leaded by North America in 2014. The region occupied the biggest share.

This was due to increasing diabetes cases, rising demand for the untimely diagnosis of diabetic retinopathy and favorable reimbursement amenities. Huge infiltration of anti-VEGF drugs in markets is a prime factor adding revenue to this region. The Europeandiabetic retinopathy market followed North America and produced the second biggest income. It was propelled forward by amplified consciousness among patients. The developing countries of Asia Pacific are anticipated to undergo significant expansion through the forecast phase.

This is because of the intensifying old population, growing disposable incomes and boosting research subsidies for diabetes.

For More Information about site: http://www.ni2014.org/

Smart Healthcare Market to 2022 – Market Estimate, Industry Size:Grand View Research, Inc.

Medical data systems offer economical and sustainable solutions for the alteration, compilation and processing of medical data and knowledge. Smart medical systems facilitate the simple recovery of health reports and patient histories. They also facilitate accessto history of patients from different geographical regions. Consequently, smart healthcare systems enable doctors and surgeons to treat patients in a better manner. These systems also provide access to significant health records of patients, thereby simplifying and enhancing doctors’ treatment procedures.

Download sample Copy of This Report at : http://www.grandviewresearch.com/industry-analysis/smart-healthcare-market

Rising demand for private healthcare (with simple data recovery) and track record is one of the important factors, steering the smart healthcare market further. Conversely, the absence of safe information storageand shortage of skilled medical personnel are the prime hindrances for the market. The various consumer sectors of the smart healthcare market are individual patients, hospitals, government medical establishments, research and development establishments and others.

The applications sector of the smart healthcare market includes remote patient monitoring, telemedicine, electronic health records, medical management and others. Rising demand for smart healthcare services across application and consumer sectors is estimated to propel the sales of the smart healthcare market. The market is expected to experience profits during the forecast period. This is on account of increasing technological innovations in the branch of medical information technology.

Moreover, the growth and surfacing of smart pills, syringes and bandages are also estimated to boost the smart healthcare market through the forecast period. Fiscal restrictions with regard to smart healthcare services and low consciousness levels in relation to the growth of above mentioned products also prevent further progress of the smart healthcare market.

Segments

The worldwide market is sliced into two segments. These include products and regions.

Products Insights

The significant products under the smart healthcare market include RFID smart cabinets, mHealth, telemedicine, smart pills, smart syringes, and electronic heath records. Electronic health records were one of the highest income producing segments in 2014. mHealth is anticipated to undergo a CAGR of more than 45 percent during the forecast phase.

The vital factors responsible for this decent CAGR are the various benefits linked with mHealth. Increased occurrence of cardiac ailments, cancer and diabetes are a factor, generating increased revenue for mHealth systems. Fast growth and augmenting buying power has led to the proliferation of smart phones. This is predicted to be a vital factor, positively affecting the mHealth and smart healthcare market.

Regions Overview

The various regions under the smart healthcare market include Europe, rest of the world, North America and Asia Pacific. North America was reportedly the biggest in 2014. The prime factor responsible for its huge share is supportive governmental initiatives. ThemHealth market in the region was estimated at about USD 999 million in 2013.

It is projected to rise at a profitable CAGR during the years ahead. The European smart healthcare market is anticipated to produce the highest income by the end of the forecast period. The Asian Pacific market is likely to boost further in the future. This is on account of supportive governmental initiatives and continually improving medical and infrastructural amenities.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information about site: http://www.ni2014.org/

Geriatric Care Services Industry to 2022 – Market Outlook, Industry Trends:Grand View Research, Inc.

The increased population of baby boomers in the United States of America is one of the prime components, driving further demand for the geriatric care services market. The market was predicted to have collected an income of about USD 560 billion in 2012. It is estimated to expand at around 6 percent CAGR during 2013 to 2019. This phase marks the forecast period. The geriatric care services market is likely to earn a revenue of around USD 850 billion by the end of the forecast period.

Download sample Copy of This Report at : http://www.grandviewresearch.com/industry-analysis/geriatric-care-services-market

Geriatric care services are inclusive of various individual care, healthcare and helpful services. The services ensure that the requirements of the elderly are met. These elderly have restrictions for self care owing to chronic illnesses, injuries, mental, physical or cognitive disabilities or other health connected problems. The services are also inclusive of aid with daily living activities, like grooming, dressing, bathing, eating, etc. These services assist people in enhancing or upholding the finest living quality and physical functioning.

Rising old population attempting to live on their own and innovations in technologies for geriatric population are also estimated to add income to the geriatric care services market. In addition to these, the growing population of oldest people susceptible to illnesses, like neurological and breathing disorders is also accountable for pushing the market ahead.

Categories And Leaders

The geriatric care services market is segmented in view of two categories. These are services and geographies. The services market includes adult day care, home care, and institutional care. The sector of institutional care occupied the biggest share in 2012. Home care followed institutional care and landed the second spot with respect to income in the geriatric care services market. It is expected to grow further during the forecast period. Institutional care is the most expensive of all care services. It offers quality care services and has been the most technologically advanced and biggest sector.

However, the feeling of being left out by the family among the elderly and high costs of institutional care are estimated to hinder the pace of this sector in the geriatric care services market. Adult day care is also anevolving sector and is estimated to notice further growth in the future. It provides various benefits. Some of these are home living, improved life quality, social communication, refreshment and skillful nursing services. These benefits augur well for the sector and steer it forward. They even promote further growth of the geriatric care services market.

The worldwide geriatric care services marketis also fragmented on account of various regions. These are Europe, rest of the world, Asia Pacific and North America. North America and Europe are anticipated to dominate the geriatric care services market through the forecast period. In urbanized countries, like Canada, the United States, Germany, Spain, France and Italy, the market is experiencing decent expansion. This is on account of the growing elderly population choosing geriatric care services.

Chronic diseases among old people, rising life expectation and restrictions in performing useful and reasoning activities are the other apparent causes for the further development of the geriatric care services market in industrialized countries.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information about site: http://www.ni2014.org/

Personalized Medicine Market to 2022 – Market Estimate, Industry Size:Grand View Research,Inc.

The worldwide personalized medicine market is projected to rise at about 9.5 percent CAGR from 2010 to 2015. This rise is estimated to be steered forward by the untimely detection of diseases and cost reductions on treatments. Additionally, drug safety, therapy optimization and patient conformity are also predicted to drive the market ahead.

Rising technological innovations and advancements in DNA technology are likely to lead towards the formation of the personalized medicine market in France, United Kingdom, China, India and Japan. The worldwide market is anticipated to experience imperative expansion in the years to come. Personalized medicines are powerful customized remedies for individual patients.

Download sample Copy of This Report at : http://www.grandviewresearch.com/industry-analysis/personalized-medicine-market

Other factors propelling the personalized medicine market forward are increased consciousness regarding health, enhancements in technologies and innovations in the medical sector. The market is also expanding further on account of rising life threatening illnesses, like cancer and AIDS. Moreover, poor lifestyles, escalating consumption of unhealthy food and amplified population of the aged are leading to increasing chronic illnesses.

These illnesses lead towards accessing personalized medicines to take care of the former. This factor also steers the sales of the personalized medicine market.

Categories

The market can be sliced on account of four categories. These include technologies, applications, products and regions. The technologies market can be divided further into point of care, stem cell therapy, pharmacoproteomics, pharmacogenetics, pharmacokinetics, pharmacodynamics and metabolomics.

The applications personalized medicine market can be segmented in view of government, diagnostics, medical and pharmaceuticals. Rising demand for personalized medicines across these sectors is also projected to drive increased demand for the market.

The products personalized medicine market can be segmented, considering PM therapeutics; PM diagnostics; personalized nutrition and wellness; and personalized medical care. The regions market is sliced on the strength of four regions. These are Asia Pacific, rest of the world, North America and Europe.

Escalating demand for personalized medicines across these regions also drives the demand for the personalized medicine market.

Leaders

The technologies market was dominated by pharmacogenomics. Point of care followed pharmacogenomics and occupied the second position. This was with respect to share in the personalized medicine market.

The applications market was leaded by medical. Medical captured majority of the shares. The products personalized medicine market was dominated by personalized nutrition and wellness. Personalized nutrition and wellness captured the biggest share.

High accessibility and large population drive this segment. PM diagnostics and PM therapeutics are predicted to rise most rapidly through the forecast period. This is on account of innovations in the sector of genetic medicine. The regions personalized medicine market was dominated by North America.

High-tech medical infrastructure, supportive governmental policies in relation to research on cancer and rising consciousness levels are the major factors, driving this region. Asia Pacific is anticipated to undergo profitable expansion through the forecast period.

High infiltration of personalized medicines and massive population are responsible for driving this region. Rising joint proposals between eastern and western market members are also estimated to steer the Asian Pacific personalized medicine market ahead.

China and India contribute revenue to this regional market. Presently, they are facing growing demand for personalized medicines.

For More Information about site: http://www.ni2014.org/

Medical oxygen concentrators Market to 2022 – Market Estimate, Industry Size

Medical oxygen concentrators have been one of the most prominentinnovative things in permanent oxygen therapy support. A medical oxygen concentrator is a healthcare instrument operated via electrical means. It is utilized to offer concentrated or refined oxygen to a patient looking for oxygen therapy.

Such an instrument functions on the norm of forcing air into itself which then detaches oxygen and continually supplies it to patients. Medical oxygen concentrators are deemed harmless, simple to utilize and economicalas against compressed oxygen cylinders. These instruments are often advised to patients suffering from chronic pulmonary illnesses.

Download sample Copy of This Report at:  http://www.grandviewresearch.com/industry-analysis/medical-oxygen-concentrators-market

Market Overview

The medical oxygen concentrators market is steered forward by the ability of oxygen concentrators to supply oxygen under all situations and global ‘growing older’ population. Increased incidences of respiratory illnesses and COPD also push further development of the market. The various benefits linked with these instruments include usage simplicity, less weight and growing affordability. These benefits augur really well for the medical oxygen concentrators market and further it both in terms of size and volume.

The worldwide market is projected to achieve a size of around USD 2 billion by 2020. Growing population of old people with lower body resistance to respiratory illnesses and COPD is also predicted to remain a vital driving factor of the medical oxygen concentrators market. Supportive initiatives of the government in respect to the utilization of portable oxygen concentrators are also anticipated to steer the sales of the market.

COPD alliance in Europe is also estimated to positively affect the medical oxygen concentrators market through the forecast period.

Categories

The various categories into which the medical oxygen concentrators market is divided are products, technologies, applications and geographical regions. The products under the market are fixed medical oxygen concentrators and portable medical oxygen concentrators. The technologies market consists of continuous flow technology and pulse dose technology.

The medical oxygen concentrators market, in view of applications, is segmented on the basis of non-home care services and home care services. The geographies market includes the regions of Asia Pacific, rest of the world, Europe and North America.

Leaders  

The products medical oxygen concentrators market was dominated by portable medical oxygen concentrators in 2014. These concentrators occupied more than 50 percent of the worldwide income. This income was attributed to growing demand for portable and lightweight concentrators at different places. Fixed medical oxygen concentrators are estimated to experience a stable growth of about 10 percent during the forecast period.

The technologies medical oxygen concentrators market noticed high infiltration from pulse dose technology in 2014. This was due to rising incidences of COPD and respiratory illnesses. Continuous flow technology, alternatively, occupied the biggest share.

The applications medical oxygen concentrators market was dominated by home care services in 2014. Home care services captured a share of more than 50 percent. This was owing to rising demand for home healthcare. Non-home care services are mostly utilized in hospitals and healthcare centers.

The geographies market was dominated by North America in 2014. Asia Pacific is the most profitable medical oxygen concentrators market during the forecast phase.

For More Information about site: http://www.ni2014.org/

Power Transformers Market to 2020 – Market Estimate, Industry Size: Grand View Research, Inc.

The global power transformers market is expected to reach USD 18.55 billion by 2020, according to a new study by Grand View Research, Inc. Growing energy demand, on a global level, is expected to be the key driving force for the power transformers market over the next six years. Favorable regulatory scenario for the development of low noise and environmentally friendly transformers is also expected to drive the market over the forecast period.

Browse full research report on Global Power Transformers Market: http://www.grandviewresearch.com/industry-analysis/power-transformers-market

Increasing investment in power plant infrastructure in developing markets of Asia Pacific is expected to boost regional demand. The market in North America and Europe is expected to primarily be driven by need for replacing aging equipment. Smart grid and super grid development initiatives are expected to be a considerable opportunity for market participants. Volatility in prices of key raw materials such as steel and copper is expected to be a barrier for industry growth.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/power-transformers-market

Further key findings from the study suggest:

• Global power transformers shipments were estimated to be 11,352 units in 2013, and are expected to reach 16,994 units by 2020, growing at a CAGR of 5.9% from 2014 to 2020.

• Power transformers with a rating of 100 MVA to 500 MVA are expected to continue dominating global demand, and accounted for over 73% of the overall market volume in 2013. It is also expected to be the fastest growing segment, at an estimated CAGR of 6.4% in terms of revenue from 2014 to 2020.

• Asia Pacific accounted for over 40% of the market in 2013; it is also expected to grow at the fastest CAGR of 6.6% in terms of revenue from 2014 to 2020. Growing population as well as increasing demand for electricity is expected to fuel the market in this region over the forecast period.

• Companies operating in the market include ABB Ltd., Alstom SA, General Electric, Siemens Energy and Toshiba Corp. among others. New product development and innovation in order to meet regulatory requirements and address growing demand are among the key strategies employed for market expansion.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/construction-and-utilities

For the purpose of this study, Grand View Research has segmented the global power transformers market on the basis of product and region:

    • Power Transformers Product Outlook (Volume, Unit Shipments and Revenue, USD Billion; 2012 - 2020)
            • 100 MVA to 500 MVA
            • 501 MVA to 800 MVA
            • 801 MVA to 1200 MVA
    • Power Transformers Regional Outlook (Volume, Unit Shipments and Revenue, USD Billion; 2012 - 2020)
            • North America
            • Europe
            • Asia Pacific
            • RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Web: www.grandviewresearch.com

Biotechnology Market Share, Analysis, Trends To 2020 by Grand View Research, Inc.

The global market for biotechnology is expected to reach USD 604.40 billion by 2020, according to a new study by Grand View Research, Inc. Increasing application scope coupled with the rising demand for effective vaccines and drugs in an attempt to improve healthcare access to patients with unmet medical needs is expected to drive market demand over the next six years. In addition, the need to enhance agricultural productivity via the use of genetically engineered seeds is expected to serve this market as a driver.

Browse full research report on Global biotechnology Market: http://www.grandviewresearch.com/industry-analysis/biotechnology-market

Biopharmacy dominated the overall market, accounting for over 60% of the total revenue in 2013. High costs associated with the drug discovery process coupled with increasing healthcare expenditures in emerging markets such as India, China and Brazil are some of the factors augmenting biopahrmacy growth. Growing popularity of contract research outsourcing (CRO) services in an attempt to curb manufacturing and R&D costs are expected to drive bioservices demand, which is expected to be the fastest growing application market for biotechnology.

Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/biotechnology-market

Further key findings from the study suggest:

• North America was the largest regional market, accounting for over 40% of global revenue in 2013, with growth being driven by the presence of sophisticated healthcare infrastructure, high patient awareness levels and healthcare expenditure.

• Asia Pacific is expected to register the fastest CAGR of 14.8% during the forecast period owing to the presence of untapped opportunities in emerging markets such as India and China.

• Tissue engineering and regeneration technology dominated the market in terms of revenue share in 2013 at 32.5% on account of the rising demand for regenerative medicine.

• Key industry participants include Novo Nordisk, Amgen, Gilead Sciences, Celgene, Biogen Idic, Teva Pharmaceutical Industries, Merck KGaA, CSL, Regeneron, Alexion Pharmaceuticals, Shire PLC, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan, Actelion, Onyx Pharmaceuticals, Dr. Reddy’s Laboratories, Seattle Genetics, Alkermes, Ariad Pharmaceuticals, Cubist Pharmaceuticals, United Therapeutics, Ipsen Group and DiaSorin.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

For the purpose of this study, Grand View Research has segmented the global biotechnology market on the basis of application and region:

    • Biotechnology Application Outlook
            • Medical Gases
            • BioPharmacy
            • BioServices
            • BioAgriculture
            • BioIndustrial
    • Biotechnology Technology Outlook
            • Fermentation
            • Tissue engineering and Regeneration
            • PCR Tehnology
            • Nanobiotechnology
            • Chromatography Market
            • DNA Sequencing
            • Cell Based Assay
            • Others
    • Biotechnology Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Web: www.grandviewresearch.com